Here, we demonstrated that LATS1 mRNA m6A modification mediated by METTL3 and recognized by YTHDF2, plays a positive role in promoting both tumorigenesis and glycolysis in breast cancer. This evidence concerns the gene METTL3 and breast carcinoma.